Health Canada
- Status: approved
🇨🇦 Boostrix IPV infant acellular Pertussis in Canada
Boostrix IPV infant acellular Pertussis (Boostrix IPV infant acellular Pertussis) regulatory status in Canada.
Marketing authorisation
Boostrix IPV infant acellular Pertussis in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Boostrix IPV infant acellular Pertussis approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Boostrix IPV infant acellular Pertussis in Canada?
London School of Hygiene and Tropical Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.